Haller Julia A — SEC insider filings
SEC reporting owner CIK 1656082. 35 insider filings on record with FilingPulse; latest filed 2026-11-06.
Transaction summary — filings shown
Covers all 35 filings on record, filed 2020-10-02 to 2026-11-06. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 3,800 shares, $240,578 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 44.
- Largest priced transaction: sale of 3,800 shares @ $63.31 ($240,578) in BRISTOL MYERS SQUIBB CO, filed 2026-11-06.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| BRISTOL MYERS SQUIBB CO (BMY) | Director | 25 | — | 1 leg · 3,800 sh · $240,578 | 28 |
| Outlook Therapeutics, Inc. (OTLK) | Director | 7 | — | — | 10 |
| EYENOVIA, INC. (EYEN) | Director | 3 | — | — | 6 |
Insider filings — Haller Julia A
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-06 | 4 | BRISTOL MYERS SQUIBB CO (BMY) | Sale (S): 3,800 @ $63.31 | EDGAR |
| 2026-06-16 | 4 | BRISTOL MYERS SQUIBB CO (BMY) | Option exercise (M): 20,460 @ $53.76 · Option exercise (M): 20,460 (derivative) @ $0 | EDGAR |
| 2026-02-03 | 4 | BRISTOL MYERS SQUIBB CO (BMY) | Grant/award (A): 3,996.37 (derivative) @ $55.05 | EDGAR |
| 2025-10-03 | 4 | Outlook Therapeutics, Inc. (OTLK) | Grant/award (A): 286,734 (derivative) @ $0 · Grant/award (A): 58,648 (derivative) @ $0 | EDGAR |
| 2025-02-04 | 4 | BRISTOL MYERS SQUIBB CO (BMY) | Grant/award (A): 3,562.34 (derivative) @ $58.95 | EDGAR |
| 2024-10-03 | 4 | Outlook Therapeutics, Inc. (OTLK) | Grant/award (A): 56,636 (derivative) @ $0 · Grant/award (A): 47,232 (derivative) @ $0 · Grant/award (A): 12,082 (derivative) @ $0 | EDGAR |
| 2024-03-08 | 4 | Outlook Therapeutics, Inc. (OTLK) | Grant/award (A): 94,441 (derivative) @ $0 | EDGAR |
| 2024-02-05 | 4 | BRISTOL MYERS SQUIBB CO (BMY) | Grant/award (A): 4,314.77 (derivative) @ $48.67 | EDGAR |
| 2024-01-03 | 4 | BRISTOL MYERS SQUIBB CO (BMY) | Grant/award (A): 706.49 (derivative) @ $51.31 | EDGAR |
| 2023-10-05 | 4 | Outlook Therapeutics, Inc. (OTLK) | Grant/award (A): 210,225 (derivative) @ $0 | EDGAR |
| 2023-10-03 | 4 | BRISTOL MYERS SQUIBB CO (BMY) | Grant/award (A): 624.57 (derivative) @ $58.04 | EDGAR |
| 2023-07-05 | 4 | BRISTOL MYERS SQUIBB CO (BMY) | Grant/award (A): 553.94 (derivative) @ $63.95 | EDGAR |
| 2023-04-04 | 4 | BRISTOL MYERS SQUIBB CO (BMY) | Grant/award (A): 486.94 (derivative) @ $69.31 | EDGAR |
| 2023-03-31 | 4 | Outlook Therapeutics, Inc. (OTLK) | Grant/award (A): 41,065 (derivative) @ $0 | EDGAR |
| 2023-02-03 | 4 | BRISTOL MYERS SQUIBB CO (BMY) | Grant/award (A): 2,807.81 (derivative) @ $71.23 | EDGAR |
| 2023-01-04 | 4 | BRISTOL MYERS SQUIBB CO (BMY) | Grant/award (A): 469.08 (derivative) @ $71.95 | EDGAR |
| 2022-10-07 | 4 | Outlook Therapeutics, Inc. (OTLK) | Grant/award (A): 42,239 (derivative) @ $0 | EDGAR |
| 2022-10-04 | 4 | BRISTOL MYERS SQUIBB CO (BMY) | Grant/award (A): 474.75 (derivative) @ $71.09 | EDGAR |
| 2022-08-15 | 4 | Outlook Therapeutics, Inc. (OTLK) | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2022-07-05 | 4 | BRISTOL MYERS SQUIBB CO (BMY) | Grant/award (A): 438.31 (derivative) @ $77 | EDGAR |
| 2022-06-21 | 4 | EYENOVIA, INC. (EYEN) | Grant/award (A): 22,222 @ $0 · Grant/award (A): 30,769 (derivative) @ $0 | EDGAR |
| 2022-06-07 | 4 | BRISTOL MYERS SQUIBB CO (BMY) | Option exercise (M): 2,949 @ $0 · Option exercise (M): 2,949 (derivative) @ $0 | EDGAR |
| 2022-04-04 | 4 | BRISTOL MYERS SQUIBB CO (BMY) | Grant/award (A): 462.14 (derivative) @ $73.03 | EDGAR |
| 2022-02-03 | 4 | BRISTOL MYERS SQUIBB CO (BMY) | Grant/award (A): 3,067.95 (derivative) @ $65.19 | EDGAR |
| 2022-01-04 | 4 | BRISTOL MYERS SQUIBB CO (BMY) | Grant/award (A): 521.25 (derivative) @ $62.35 | EDGAR |
| 2021-11-22 | 4 | EYENOVIA, INC. (EYEN) | Grant/award (A): 6,963 @ $0 · Grant/award (A): 9,653 (derivative) @ $0 | EDGAR |
| 2021-10-01 | 4 | BRISTOL MYERS SQUIBB CO (BMY) | Grant/award (A): 549.26 (derivative) @ $0 | EDGAR |
| 2021-07-01 | 4 | BRISTOL MYERS SQUIBB CO (BMY) | Grant/award (A): 487.00 (derivative) @ $0 | EDGAR |
| 2021-06-14 | 4 | BRISTOL MYERS SQUIBB CO (BMY) | Option exercise (M): 902 @ $0 · Option exercise (M): 902 (derivative) @ $0 | EDGAR |
| 2021-06-04 | 4 | BRISTOL MYERS SQUIBB CO (BMY) | Option exercise (M): 2,949 @ $0 · Option exercise (M): 2,949 (derivative) @ $0 | EDGAR |
| 2021-04-02 | 4 | BRISTOL MYERS SQUIBB CO (BMY) | Grant/award (A): 514.81 (derivative) @ $63.13 | EDGAR |
| 2021-04-01 | 4 | EYENOVIA, INC. (EYEN) | Grant/award (A): 1,223 @ $0 · Grant/award (A): 1,637 (derivative) @ $0 | EDGAR |
| 2021-02-03 | 4 | BRISTOL MYERS SQUIBB CO (BMY) | Grant/award (A): 3,054.17 (derivative) @ $62.21 | EDGAR |
| 2021-01-05 | 4 | BRISTOL MYERS SQUIBB CO (BMY) | Grant/award (A): 523.94 (derivative) @ $62.03 | EDGAR |
| 2020-10-02 | 4 | BRISTOL MYERS SQUIBB CO (BMY) | Grant/award (A): 539.06 (derivative) @ $60.29 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-09-28 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1656082 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs